Databases analyses revealed that NMT2 expression levels varied significantly more than those of NMT1, and that hematologic cancer cell lines comprised the vast majority of the lowest NMT2 expressing cells [22]. This evidence concerns the gene NMT2 and hematopoietic and lymphoid cell neoplasm.